AGEN vs JAZZ · P/E 1.6, rev $68.3M vs P/E 1988, rev $2.28B
Agenus Inc (AGEN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AGEN and JAZZ stock pages for the full models.
Not investment advice.